6 terminated. 6 Phase 1, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Terminated 6 |
| Phase 2 | 5 | Terminated 5 |
Follow Hydrocortisone: new trials by email Literature Review of Hydrocortisone trials Research Report on Hydrocortisone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HAT for the Treatment of Sepsis Associated With NASTI HAT, Placebo - Necrotizing Soft Tissue Infection, Sepsis | Phase 1 / Phase 2 | Terminated | Ascension Health | 10 | 2021-09-10 | 2024-07-24 |
| EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) EZN-3042, Cytarabine, Doxorubicin - Lymphoblastic Leukemia, Acute, Lymphoblastic Leukemia, Acute, Childhood | Phase 1 | Terminated | Therapeutic Advances in Childhood Leukemia Consortium | 6 | 2010-08-24 | 2024-02-01 |
| Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer ketoconazole, hydrocortisone, dutasteride - Prostate Cancer | Phase 1 / Phase 2 | Terminated | Dana-Farber Cancer Institute | 11 | 2009-09-29 | 2018-09-04 |
| Effects of Fludrocortisone and Hydrocortisone in Healthy Volunteers With Aldosterone Induced Suppression Fludrocortisone, Hydrocortisone, Placebo of Fludrocortisone - Renin Angiotensin | Phase 1 / Phase 2 | Terminated | Rennes University Hospital | 13 | 2008-05-01 | 2012-03-02 |
| Ifosfamide, Carboplatin, Etoposide, and SGN-30 in Treating Young Patients With Recurrent Anaplastic Large Cell Lymphoma monoclonal antibody SGN-30, therapeutic hydrocortisone, ifosfamide - Anaplastic Large Cell Lymphoma, Recurrent Childhood Anaplastic Large Cell Lymphoma | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 5 | 2007-01-01 | 2018-03-14 |
| Calcitriol in Combination With Ketoconazole and Therapeutic Hydrocortisone in Treating Patients With Prostate Cancer Calcitriol, Ketoconazole, Laboratory Biomarker Analysis - Prostate Adenocarcinoma, Recurrent Prostate Carcinoma | Phase 1 / Phase 2 | Terminated | Roswell Park Cancer Institute | 51 | 2006-10-01 | 2017-06-14 |
Prostatic Neoplasms (2) · Leukemia (1) · Lymphoma, Large-Cell, Anaplastic (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1) · Recurrence (1) · Sepsis (1)
Ascension Health (1) · Dana-Farber Cancer Institute (1) · National Cancer Institute (NCI) (1) · Rennes University Hospital (1) · Roswell Park Cancer Institute (1) · Therapeutic Advances in Childhood Leukemia Consortium (1)
United States (5) · Australia (1) · France (1)
Elizabeth Raetz, MD (1) · Glenn Bubley, MD (1) · John Sandlund (1) · Saby George (1) · Thomas Resch, M.D. (1) · William Carroll, MD (1)
P30CA016056 (1), U10CA098543 (1)